The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Guy Griebel

Central Nervous System Research Department

Sanofi-Synthelabo

Bagneux

France

[email]@sanofi-synthelabo.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Central Nervous System Research Department, Sanofi-Synthelabo, Bagneux, France. 2002 - 2003
  • Sanofi-Synthelabo Recherche, Bagneux, France. 2003
  • Sanofi-Synthélabo, 31 Avenue Paul Vaillant-Couturier, 92220, Bagneux, France. 2000 - 2002

References

  1. SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms. Griebel, G., Perrault, G., Simiand, J., Cohen, C., Granger, P., Depoortere, H., Françon, D., Avenet, P., Schoemaker, H., Evanno, Y., Sevrin, M., George, P., Scatton, B. CNS. Drug. Rev (2003) [Pubmed]
  2. The vasopressin V1b receptor as a therapeutic target in stress-related disorders. Griebel, G., Simiand, J., Stemmelin, J., Gal, C.S., Steinberg, R. Curr. Drug. Targets. CNS. Neurol. Disord (2003) [Pubmed]
  3. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. Griebel, G., Simiand, J., Steinberg, R., Jung, M., Gully, D., Roger, P., Geslin, M., Scatton, B., Maffrand, J.P., Soubrié, P. J. Pharmacol. Exp. Ther. (2002) [Pubmed]
  4. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.P., Soubrie, P. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  5. Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents. Griebel, G., Perrault, G., Soubrié, P. Psychopharmacology (Berl.) (2001) [Pubmed]
  6. Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery. Griebel, G., Moindrot, N., Aliaga, C., Simiand, J., Soubrié, P. Neurosci. Biobehav. Rev (2001) [Pubmed]
  7. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety. Griebel, G., Rodgers, R.J., Perrault, G., Sanger, D.J. Neuropharmacology (2000) [Pubmed]
 
WikiGenes - Universities